Skip to main content
SpringerLink
Log in

p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Gastric cancer is more than twice as common in Hispanics as in Anglos in Texas, while colorectal cancer is almost twice as common in Anglos as Hispanics. To test the hypothesis that mutations in the p53 tumour suppressor gene are involved in these differences, we examined 131 gastric and 138 colorectal cancers from Hispanic and Anglo patients from South Texas and Mexico using immunohistochemistry (IHC) as a screening assay for p53 mutations. The fraction of p53 positive cases was not significantly different in gastric cancers from Hispanics compared to Anglos (43% versus 61%, respectively, p=0.13) or in colorectal cancer (57% versus 58%, respectively, p=1.0), suggesting that p53 mutations are not involved in causing the different incidences of these cancers in these populations. In addition, the types of p53 mutations arising in gastric tumours from Hispanic patients were consistent with those reported in gastric tumours in other populations. Sequencing of mutations in five gastric cancers revealed two G: C to A: T transitions, two A: T to G: C transitions and one complex deletion. In contrast with findings in studies in other tumour types, neither stage nor survival was associated with p53 positive staining by IHC in either gastric or colorectal tumours in this study. Positive p53 immunostaining was associated with the diffuse histological subtype in gastric carcinoma (p=0.05) and high histological grade in colorectal carcinoma (p=0.04).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agarwal RC, Wiessler M, Hecker E, Bhide SV (1986) Tumourpromoting effect of chili extract in Balb/c mice. Int J Cancer 38:689–695

    Google Scholar 

  • Allred DC, Clark GM, Elledge R, Fuqua S, Brown RW, Chamness GC, Osborne CK, McGuire WL (1993) Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200–206

    Google Scholar 

  • Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JKV, Hamilton S, Vogelstein B (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717–7722

    Google Scholar 

  • Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (1992) Manual for staging of cancer. J.B. Lippincott, Philadelphia, chaps 10, 12

    Google Scholar 

  • Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, Taylor GR, Dixon MF, Quirke P (1993) Prognostic value of p53 over-expression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 104:57–64

    Google Scholar 

  • Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF, Linnoila RI (1992) Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7:743–749

    Google Scholar 

  • Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC (1993) p53 is mutated in a subset of advance-stage prostate cancers. Cancer Res 53:3369–3373

    Google Scholar 

  • Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429–431

    Google Scholar 

  • Campo E, de la Calle-Martin O, Miguel R, Palacin A, Romero M, Fabregat V, Vives J, Cardisa A, Yague J (1991) Loss of heterogygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 51:4436–4442

    Google Scholar 

  • Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, Taylor N, Mackinley D, de Lima E, Portillo H, Zarama G (1990) Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 66:2569–2574

    Google Scholar 

  • Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, Kovach JS, Thibodeau SN (1992) Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 52:1974–1980

    Google Scholar 

  • Ehrlich M, Wang R Y.-H. (1981) 5-Methylcytosine in eukaryotic DNA. Science 212:1350–1357

    Google Scholar 

  • Finlay CA, Hinds PW, Tan T-H, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms a hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531–539

    Google Scholar 

  • Forman D, Silas F, Newell DG, Stacey AR, Boreham J, Peto R, Campbell TC, Li J, Chen J (1990) Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 46:608–611

    Google Scholar 

  • Hensel CH, Xiang RH, Sakaguchi AY, Naylor SL (1991) Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer. Oncogene 6:1067–1071

    Google Scholar 

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53

    CAS  PubMed  Google Scholar 

  • Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428

    Google Scholar 

  • Imazeki F, Omata M, Nose H, Ohto M, Isono K (1992) p53 Gene mutations in gastric and esophageal cancers. Gastroenterology 103:892–896

    Google Scholar 

  • Isola J, Visakorpi T, Holli K, Kallioniemi OP (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109–1114

    Google Scholar 

  • Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K (1993) Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 67:589–593

    Google Scholar 

  • Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, Iino H, Fukayama M, Koike M, Mori T, Sakuraba H, Fukunari H, Iwama T, Miyaki M (1992) Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 52:3965–3971

    Google Scholar 

  • Kim J-H, Takahashi T, Chiba I, Park J-G, Birrer MJ, Roh JK, Lee HD, Kim J-P, Minna JD, Gazdar AF (1991) Occurrence of p53 gene abnormalities in gastric carcinoma tumours and cell lines. J Natl Cancer Inst 83:938–943

    Google Scholar 

  • Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49

    CAS  PubMed  Google Scholar 

  • Lawson T, Gannett P (1989) The mutagenicity of capsaicin and dihydrocapsaicin in V79 cells. Cancer Lett 48:109–113

    Google Scholar 

  • Loffeld RJLF, Willems I, Flendrig JA, Arends JW (1990) Helicobacter pylori and gastric carcinoma. Histopathology 17:537–541

    Google Scholar 

  • Malaty HM, Evans DG, Evans DJ, Graham DY (1992) Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 103:813–816

    Google Scholar 

  • Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859–862

    Google Scholar 

  • Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, Wada K, Nishisaki H, Konda Y, Nagao M, Kasuga M (1992) p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res 52:4335–4341

    Google Scholar 

  • Mor O, Grossman Z, Jakobovitz O, Brok SF, Rechavi G (1992) Artifactual p53 point mutations: possible effect of gene secondary structure on PCR and direct sequence analysis. Lancet 340:1236–1236

    Google Scholar 

  • Nagabhushan M, Bhide SV (1985) Mutagenicity of chili extract and capsaicin in short-term tests. Environ Mutagen 7:881–888

    Google Scholar 

  • Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins TS, Weston A, Modali R, Harris C, Vogelstein B (1989) Mutations in the p53 gene occur in diverse tumor types. Nature 342:705–708

    Google Scholar 

  • Nomura A, Stimmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132–1136

    CAS  PubMed  Google Scholar 

  • Oren M (1985) The p53 cellular tumor antigen: gene structure, expression and protein properties. Biochim Biophys Acta 823:67–78

    Google Scholar 

  • Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879

    CAS  PubMed  Google Scholar 

  • Parkin DM, Läärä E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184–197

    Google Scholar 

  • Parsonnet J, Freidman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991a) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131

    CAS  PubMed  Google Scholar 

  • Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y (1991b) Helicobacter infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83:640–643

    Google Scholar 

  • Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM (1992) Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52:4828–4831

    Google Scholar 

  • Renault B, van den Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM, Ranzani GN (1993) Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 53:2614–2617

    Google Scholar 

  • Sarkis AS, Dalbagni G, Cordon CC, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE (1993) Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 85:53–59

    CAS  PubMed  Google Scholar 

  • Scott N, Sagar P, Steward J, Blair GE, Dixon MF, Quirke P (1991) p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 63:317–319

    Google Scholar 

  • Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobrinho-Simões M, Borresen AL (1992) p53 mutations in gastric carcinomas. Br J Cancer 65:708–710

    Google Scholar 

  • Shaulsky G, Goldfinger N, Ben-Ze'ev A, Rotter V (1990) Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol 10:6565–6577

    Google Scholar 

  • Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G (1992) Frequent p53 mutations in head and neck cancer. Cancer Res 52:5997–6000

    Google Scholar 

  • Starzynska T, Bromley M, Ghosh A, Stern PL (1992) Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66:558–562

    Google Scholar 

  • Sun XF, Carstensen JM, Zhang H, St»l O, Wingren S, Hatschek T, Nordenskjöld B (1992) Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340:1369–1373

    Google Scholar 

  • Tamura G, Kihana T, Nomura K, Terada M, Sugimura T, Hirohashi S (1991) Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 51:3056–3058

    Google Scholar 

  • Texas Department of Health. Texas Cancer Incidence Data (1976–1985).

  • Thor AD, Moore DH, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith HS (1992) Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845–855

    Google Scholar 

  • Toth B, Rogan E, Walker B (1984) Tumorigenicity and mutagenicity studies with capsaicin of hot peppers. Anticancer Res 4:117–120

    Google Scholar 

  • Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J (1992) Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 84:883–887

    Google Scholar 

  • Vojtesek B, Bártek J, Midgley CA, Lane DP (1992) An immunochemical analysis of the human nuclear phosphoprotein p53. J Immunol Methods 151:237–244

    Google Scholar 

  • Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T, Terada M (1991) p53 Gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res 51:5800–5805

    Google Scholar 

  • Yamaguchi A, Kurosaka Y, Fushida S, Kanno M, Yonemura Y, Miwa K, Miyazaki I (1992) Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 70:2778–2784

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., 78284, San Antonio, Texas, USA

    B. G. Schneider, V. Pekkel, C. H. Shelton, D. R. Pulitzer & D. C. Allred

  2. Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

    S. G. Hilsenbeck

  3. Department of Cellular and Structural Biology, University of Texas Health Science, Center at San Antonio, San Antonio, Texas, USA

    C. H. Hensel

  4. Hospital General de México, Universidad Nacional Autónoma, Mexico City, Mexico

    H. A. Rodríguez-Martínez & M. E. Gutiérrez-Díaz C.

Authors
  1. B. G. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Pekkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. H. Shelton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. R. Pulitzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. C. Allred
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. G. Hilsenbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. H. Hensel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. A. Rodríguez-Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. E. Gutiérrez-Díaz C.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, B.G., Pekkel, V., Shelton, C.H. et al. p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos. Vichows Archiv A Pathol Anat 424, 187–193 (1994). https://doi.org/10.1007/BF00193499

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00193499

Key words

Search

Navigation